Accupril and Hallucination, auditory - a phase IV clinical study of FDA data

Summary:

Hallucination, auditory is reported as a side effect among people who take Accupril (quinapril hydrochloride), especially for people who are male, 40-49 old, also take Zyprexa, and have Pain.

The phase IV clinical study analyzes which people have Hallucination, auditory when taking Accupril. It is created by eHealthMe based on reports of 13,164 people who have side effects when taking Accupril from the FDA, and is updated regularly.

What is Accupril?

Accupril has active ingredients of quinapril hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 13,404 Accupril users. Check the latest studies of Accupril.

What is Hallucination, auditory?

Hallucination, auditory (perceiving sounds without auditory stimulus) is found to be associated with 840 drugs and 1,054 conditions by eHealthMe. Check the latest studies of Hallucination, auditory.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

13,164 people reported to have side effects when taking Accupril.
Among them, 12 people (0.09%) have Hallucination, auditory.

Could Accupril cause Hallucination, auditory?

Among these 12 people:

What is the gender of people who have Hallucination, auditory when taking Accupril? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Hallucination, auditory when taking Accupril? *

What are other drugs people take besides Accupril? *

What are other side effects people have besides Hallucination, auditory? *

Chest Pain: 7 people, 58.33%
Dyspnea (difficult or laboured breathing): 6 people, 50.00%
Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 5 people, 41.67%
Emotional Distress: 5 people, 41.67%
Erection Problems: 5 people, 41.67%
Angina Unstable (chest pain due to ischemia of the heart muscle- unstable): 5 people, 41.67%
Suicide Attempt: 5 people, 41.67%
Suicidal Ideation: 5 people, 41.67%
Headache (pain in head): 5 people, 41.67%
Sinusitis (inflammation of sinus): 4 people, 33.33%

What are the existing conditions these people have? *

Pain: 4 people, 33.33%
Bipolar Disorder (mood disorder): 2 people, 16.67%
Schizophrenia, Paranoid Type (delusions and auditory hallucinations but relatively normal intellectual functioning and expression of affect): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Accupril and have Hallucination, auditory?

- Check whether Hallucination, auditory is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Accupril:

Accupril (13,404 reports)

Browse all side effects of Accupril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hallucination, auditory:

Hallucination, auditory (840 drugs)

Browse all the conditions that are associated with Hallucination, auditory:

Hallucination, auditory (1,054 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on quinapril hydrochloride (the active ingredients of Accupril) and Accupril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.